Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline

Lombard Medical Technologies PLC Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   44
ISBN Number   not applicable
Product Code   GMD698
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a Lombard Medical Technologies PLC's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Industry Outlook - Cardiovascular Devices
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Competitors
  • 6 Key Employees
  • 7 Key Employee Biographies
  • 8 Company Statement
  • 9 Locations And Subsidiaries
    • 9.1 Head Office
    • 9.2 Other Locations & Subsidiaries
  • 10 Recent Developments
    • 10.1 Financial Announcements
      • 10.1.1 Jul 24, 2008: Lombard Medical Reports 1H 2008 Results
      • 10.1.2 Mar 20, 2008: Lombard Medical Reports 2007 Results
      • 10.1.3 Jun 15, 2007: Lombard Medical Reports 2006 Results
      • 10.1.4 Mar 22, 2006: Lombard Medical Reports Full Year 2005 Results
      • 10.1.5 Jan 19, 2006: Lombard Medical CEO Buys Company Shares
    • 10.2 Corporate Communications
      • 10.2.1 Jan 09, 2007: Lombard Medical Announces Board Change
      • 10.2.2 Feb 15, 2006: Lombard Medical Announces Issue Of Shares
    • 10.3 Product News
      • 10.3.1 Apr 30, 2008: US EndoRefix Pivotal Trial commences
      • 10.3.2 Apr 17, 2008: Lombard Medical Gets FDA Approval Of Aorfix As Modular PMA
      • 10.3.3 Nov 19, 2007: Aorfix Successfully Passes 21- Patient Case Review By FDA
      • 10.3.4 Oct 22, 2007: CE Mark And Conditional IDE Approval Received For Second-Generation EndoRefix
      • 10.3.5 Jul 30, 2007: Lombard Medical Receives Full FDA Approval Of Its Supplemental IDE To Pivotal US Clinical Trial
      • 10.3.6 Jul 13, 2007: First US Case In A Patient With A High Angle Neck Aneurysm Using Gen II Aorfix
      • 10.3.7 May 29, 2007: Lombard Medical Receives Conditional FDA Approval Of Its Supplemental IDE To Pivotal US Clinical Trial
      • 10.3.8 May 22, 2007: First Cases For Aorfix In Brazil
      • 10.3.9 Apr 23, 2007: Lombard Medical Announces Filing Of Supplemental IDE To Pivotal US Clinical Trial For Aorfix And Provides Progress Update
      • 10.3.10 Apr 04, 2007: Lombard Medical Receives FDA Approval Of Its Supplemental IDE To Use Gen II Aorfix In Pivotal US Clinical Trial
    • 10.4 Product Approvals
      • 10.4.1 Apr 17, 2008: Lombard Medical Gets FDA Approval Of Aorfix As Modular PMA
      • 10.4.2 Oct 22, 2007: CE Mark And Conditional IDE Approval Received For Second-Generation EndoRefix
      • 10.4.3 Jul 30, 2007: Lombard Medical Receives Full FDA Approval Of Its Supplemental IDE To Pivotal US Clinical Trial
      • 10.4.4 May 29, 2007: Lombard Medical Receives Conditional FDA Approval Of Its Supplemental IDE To Pivotal US Clinical Trial
      • 10.4.5 Apr 04, 2007: Lombard Medical Receives FDA Approval Of Its Supplemental IDE To Use Gen II Aorfix In Pivotal US Clinical Trial
    • 10.5 Clinical Trials
      • 10.5.1 Apr 30, 2008: US EndoRefix Pivotal Trial commences
      • 10.5.2 Nov 19, 2007: Aorfix Successfully Passes 21- Patient Case Review By FDA
      • 10.5.3 Jul 13, 2007: First US Case In A Patient With A High Angle Neck Aneurysm Using Gen II Aorfix
      • 10.5.4 May 22, 2007: First Cases For Aorfix In Brazil
      • 10.5.5 Apr 23, 2007: Lombard Medical Announces Filing Of Supplemental IDE To Pivotal US Clinical Trial For Aorfix And Provides Progress Update
  • 11 Lombard Medical Technologies PLC Pipeline Products
    • 11.1 Lombard Medical Technologies PLC Product Pipeline Analysis
      • 11.1.1 Lombard Medical Technologies PLC Pipeline Products By Equipment Type
      • 11.1.2 Lombard Medical Technologies PLC Pipeline Products By Development Stage
      • 11.1.3 Lombard Medical Technologies PLC Pipeline Products By Therapy Area
      • 11.1.4 Lombard Medical Technologies PLC Pipeline Products By Clinical Trials
      • 11.1.5 Lombard Medical Technologies PLC Pipeline Products By News Summary
    • 11.2 EndoRefix
      • 11.2.1 Product Description
      • 11.2.2 Product Status
      • 11.2.3 Clinical Trials
      • 11.2.4 Product Milestone
    • 11.3 Aorfix
      • 11.3.1 Product Description
      • 11.3.2 Product Status
      • 11.3.3 Clinical Trials
      • 11.3.4 Product Milestone
    • 11.4 Low Profile Stent Graft
      • 11.4.1 Product Description
      • 11.4.2 Product Status
    • 11.5 PEP Polymer
      • 11.5.1 Product Description
      • 11.5.2 Product Status
  • 12 Appendix
    • 12.1 Methodology
      • 12.1.1 Coverage
      • 12.1.2 Secondary Research
      • 12.1.3 Primary Research
      • 12.1.4 Expert Panel Validation
    • 12.2 Contact Us
    • 12.3 About Global Markets Direct
    • 12.4 Disclaimer
  • 1 List of Tables
    • Table 1: Lombard Medical Technologies PLC,Key Facts
    • Table 2: Lombard Medical Technologies PLC, Key Employees,
    • Table 3: Lombard Medical Technologies PLC, Other Locations
    • Table 4: Lombard Medical Technologies PLC Pipeline Products by Equipment Type
    • Table 5: Lombard Medical Technologies PLC Pipeline Products By Development Stage
    • Table 6: Lombard Medical Technologies PLC Pipeline Products By Therapy Area
    • Table 7: Lombard Medical Technologies PLC Pipeline Products By Clinical Trials
    • Table 8: Lombard Medical Technologies PLC Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: Lombard Medical Technologies PLC Pipeline Products By Development Stage
    • Figure 2: Global Markets Direct Methodology